South Korea-based SK bioscience, an innovative vaccine and biotech company, has decided to make an equity investment in ...
Bio Farma Induk Holding BUMN Pharmacy, with its subsidiaries Kimia Farma and Indofarma, in collaboration with Merck Shar...
Toyo Ink SC Holdings, the parent company of Japan-based specialty chemicals manufacturer Toyo Ink Group, has concluded...
Zuellig Pharma, one of the largest healthcare services groups in Asia, has entered into an agreement with global biophar...
What are the key opportunities and challenges for APAC vaccine manufacturers in adopting and utilising mRNA technology?&...
GC Biopharma, a South Korean biopharmaceutical company, has announced that its quadrivalent flu vaccine called GC F...
GSK Singapore commemorated the groundbreaking ceremony for its S$343 million state-of-the-art vaccines facility at Tuas ...
Lifera, a biopharmaceutical company in Saudi Arabia together with French multinational pharmaceutical and healthcar...
South Korea-based biotech firm SK bioscience has signed a Memorandum of Understanding (MoU) with the Government Pha...
British firm GlaxoSmithKline (GSK) has announced that the Japanese Ministry of Health, Labour and Welfare (MHL...
SK bioscience, a global innovative vaccine and biotech company based in South Korea, has signed a collaboratio...
The International Vaccine Institute (IVI) and Seoul National University signed an agreement to expand collaboration in r...
Vaxxas, a clinical-stage biotechnology company commercialising a novel vaccination platform technology, has announced th...
South Korea-based International Vaccine Institute (IVI) and Institut Pasteur de Dakar (IPD) in West Africa, have signed ...
According to a recent study sponsored by Merck, a leading science and technology company, mRNA technology is a “ga...
SK bioscience, based in South Korea, has announced the UK’s Medicines and Healthcare products Regulatory Agency (M...
For reasons not yet fully understood, beginning in 2022 the world experienced an unprecedented surge in cholera outbreak...
South Korea-based International Vaccine Institute (IVI) has sigend a Memorandum of Understanding (MoU) with Nankai ...
Recombinant bivalent COVID-19 protein vaccine (Sf9 cells) and recombinant trivalent COVID-19 trimeric protein vaccine (S...
TechInvention Lifecare in India, has partnered with Eubiologics Co. in South Korea, to launch Euv...
Jean-Yves Duclos, Minister of Health, and Harjit S. Sajjan, Minister of International Development and Minister responsib...
The International Vaccine Institute (IVI), based in South Korea, has begun clinical development of DuoChol, a new low-co...
American pharmaceutical firm Pfizer Inc. has announced that the US Food and Drug Administration (FDA) has approved PREVN...
The results from a new YouGov survey called, ‘What’s Next for COVID-19 in Singapore?’, commissioned by...
Many disease-causing bacteria like Streptococcus pneumoniae (S. pneumoniae) are encased in a sugar layer called the caps...
Beijing Minhai Biotechnology Co., (BioMinhai), a wholly-owned subsidiary of China-based Shenzhen Kangtai Biological Prod...
Sanofi and the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic ...
DXVX has announced that its affiliated company Oxford Vacmedix (OVM) has completed Phase 1a trial of cancer vaccine and ...
Australian biotech firm CSL recently celebrated the official opening of the company's new state-of-the-art research and ...
Victoria University of Wellington and University of Auckland, in New Zealand (NZ) have been named as co-hosts of a ...
American pharmaceutical firm Pfizer has announced that the Singapore Health Sciences Authority (HSA) has approved its 20...
Likang Life Sciences has received National Medical Products Administration (NMPA) approval for the clinical trial of its...
RVAC Medicines, Inc., a messenger RNA (mRNA) technology company with its global headquarters in Singapore, has anno...
Japanese pharmaceutical company Takeda's dengue vaccine, QDENGA (Dengue Tetravalent Vaccine [Live, Attenuated...
South Korean firm LG Chem has announced that it will supply essential vaccines, including polio vaccines, for infants an...
Australia's University of Sydney medical and science researchers will be involved in two successful Cooperative Res...
Clover Biopharmaceuticals has entered into an exclusive agreement with Adimmune Corporation for Clover to dist...
GC Biopharma, a leading provider of biopharmaceutical products in South Korea, has announced that the World Health Organ...
Australia's University of Queensland (UQ)-led research effort to develop an mRNA vaccine against Group A Streptococcus (...
Clover Biopharmaceuticals has announced that the launch of its COVID-19 vaccine, a recombinant SARS-CoV-2 subunit v...
SK bioscience, a South Korea-based innovative vaccine and biotech company committed to promoting human health from preve...
Japan-based Mitsubishi Chemical Group has decided to cease all of its operations at Medicago Inc., a Canadian subs...
New South Wales (NSW) in Australia is further expanding free access to Japanese encephalitis (JE) vaccine to ensure resi...
The International Vaccine Institute (IVI), based in Seoul (South Korea) has launched an IVI Country Office in&...
Genexine, a clinical-staged Korean biopharmaceutical company committed to the discovery and development of novel biologi...
US-based Novavax, Inc. has announced that partner SK bioscience, based in South Korea, has received expanded manufacturi...
In a historic move in the global fight against the COVID-19 pandemic, the United Arab Emirates (UAE) has announced the c...
Gachon University, the Korea mRNA Vaccine Initiative (KmVAC), and the International Vaccine Institute (IVI) recently exc...
South Korea headquatered SK bioscience, a global innovative vaccine and biotech company, has received a biologics licens...
The University of Queensland (UQ) team has become the biggest supplier of experimental mRNA vaccines and therapies ...
The International Vaccine Institute (IVI), a South Korea-based international organisation devoted to vaccines for global...
On December 2nd, a nasal spray COVID-19 vaccine, VectorFlu ONE, was approved for emergency use (EU) by the national auth...
Bio Farma, Holding SOE Pharmacy – with its subsidiaries Kimia Farma and Indofarma, has signed a framework agreemen...
Chinese biotech startup Stemirna Therapeutics has received an Emergency Use Authorisation (EUA) from the FDA for ...
Malaysia's Pharmaniaga LifeScience Sdn Bhd (PLS) and Pharmaniaga Berhad have signed a Research Collaboration Agreem...
Moderna, Inc., has announced its Singapore subsidiary with a new leadership announcement. Evelyn Pang has been ap...
Japanese pharmaceutical firm Takeda has announced that the European Commission (EC) has granted marketing authorisation ...
Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) is expanding its world-leading portfolio of potentia...
Vaxxas has completed a financing round which raised $23 million (A$34 million) in new funds. This investment round was l...
Norway-based CEPI, the Coalition for Epidemic Preparedness Innovations, is to put $5.7 million (AU$8.5 million) into the...
Chinese firm XtalPi is embarking on a strategic collaboration with CK Life Sciences, a member of the CK Hutchison Group....
The International Vaccine Institute (IVI) and ST Pharm have exchanged a Memorandum of Understanding (MoU) to establish a...
SK bioscience, a leading vaccine manufacturer based in the Republic of Korea and a key partner of the International Vacc...
Researchers from the Centenary Institute and the University of Sydney in Australia have developed a new nasal vaccinatio...
The International Vaccine Institute (IVI), in South Korea, has signed a memorandum of understanding (MOU) with Lemonex, ...
US-based Arcturus Therapeutics Holdings Inc. has announced a strategic collaboration with CSL Seqirus, a global vaccine ...
Singapore-based Hilleman Laboratories has announced collaberative efforts to develop a thermostable second-generati...
CanSino Biologics has announced that its recombinant COVID-19 vaccine (Adenovirus Type 5 Vector) for inhalation (Convide...
Globally, mass vaccination practices and procedures were not pleasant experiences for everyone. Different age groups and...
South Korea's SK bioscience has entered a strategic partnership with Singapore based Hilleman Laboratories to co-develop...
South Korea-based SK bioscience has made a new partnership agreement with Norway-based Coalition for Epidemic Preparedne...
Swiss firm LimmaTech Biologics AG has announced a license and collaboration agreement with Griffith University...
PT Etana Biotechnologies Indonesia (Etana) on 7 October, 2022, inaugurated a biopharmaceutical factory located...
Immuno Cure BioTech, a clinical stage biotechnology group based in the Hong Kong Science Park specialising in DNA vaccin...
Japanese pharmaceutical firm Takeda has announced that the Committee for Medicinal Products for Human Use...
Singapore Health Sciences Authority (HSA) has granted an interim authorisation for the use of Moderna’s Omicr...
South Korea-based International Vaccine Institute (IVI) and the London School of Hygiene & Tropical Medicine (LSHTM)...
South Korea-based International Vaccine Institute (IVI) has signed a three-year Memorandum of Understanding (MoU) with H...
Veteran public health leader Anuradha Gupta, who has spearheaded a host of successful global initiatives to improve the ...
Indonesia's PT Bio Farma (Persero), the holding company for pharmaceutical state-owned enterprises (SOEs), will export i...
The University of Sydney and The Centenary Institute, together with collaborators have been awarded an AU$19 million con...
The Australian government is investing in a new study on COVID-19 vaccines and infection to ultimately improve the care ...
Singapore Health Sciences Authority (HSA) has granted an interim authorisation for the use of Moderna’s Omicr...
New research suggests recommended vaccinia virus (VACV)-based vaccines will mount a robust immune response against the m...
CanSino Biologics Inc has announced that the National Medical Products Administration of China (NMPA) has granted the co...
PT Bio Farma, the holding company for state-owned pharmaceutical companies in Indonesia, has nnounced a new milestone in...
The new in vivo-jetRNA®+ transfection reagent an efficient, stable, and safe delivery system leading to 100% mR...
Indian firm Bharat Biotech has announced that iNCOVACC (BBV154) has received approval under Restricted Use in Emergency ...
China-based Sinovac Biotech has announced that the Chilean Public Health Institute (Instituto de Salud Pública, I...
Japanese firm Takeda has announced that the company’s dengue vaccine, QDENGA (Dengue Tetravalent Vaccine [Live, At...
Australia's Monash University has announced that US-based firm Moderna will be joining other world-leading research and ...
Commonwealth Scientific and Industrial Research Organisation (CSIRO), an Australian Government agency responsible for sc...
The Coalition for Epidemic Preparedness Innovations (CEPI), Norway has announced funding of up to $375,000 to the UK Med...
As of July 2022, uncertainty persists as waves of SARS-CoV-2 continue to emerge. Over time, new virus variants arise and...
Argentina-based Biogénesis Bagó, an international biotechnology company focused on animal health and globa...
South Korea-based International Vaccine Institute (IVI) and US-based Moderna have signed a Memorandum of Understanding (...
South Korea's SK bioscience has extended its partnership with Novavax, a US-based biotechnology company specializing in ...
Pristine Biologicals NZ, a subsidiary of Indian Immunologicals Ltd (IIL) has inaugurated a new facility in Dargaville fo...
SK bioscience has announced that ‘SKYCovione,’ South Korea’s first COVID-19 vaccine candidate adjuvant...
China's Clover Biopharmaceuticals, a global clinical-stage biotechnology company developing novel vaccines and biol...
